Skip to main content
. 2023 Dec 20;11(4):433–448. doi: 10.2478/jtim-2023-0002

Figure 4.

Figure 4

Methylation alteration analysis of GOLT1B. (A) Promoter methylation level of GOLT1B in multiple tumors via the UALCAN. (B) Analysis of the relationships among GOLT1B methylation levels at specific probes (cg07371838 and cg25816357) and survival time in MethSurv. ACC: adrenocortical carcinoma; BRCA: breast invasive carcinoma, ESCA: esophageal carcinoma; GBM: glioblastoma multiforme; HNSC: head and neck squamous cell carcinoma; KIRC: kidney renal clear cell carcinoma; LAML: acute myeloid leukemia; LIHC: liver hepatocellular carcinoma; LUAD: lung adenocarcinoma; MESO: mesothelioma; PAAD: pancreatic adenocarcinoma; PRAD: prostate adenocarcinoma; SARC: sarcoma; STAD: stomach adenocarcinoma. The meaning of * is " *P < 0.05, **P < 0.01.